Fritextsökning
Innehållstyper
-
Rapid system for surface hygiene monitoring
The Clean-Trace Surface Testing Instruments are a rapid solution to monitor biological contamination on surfaces in real time to help customers manage their cle...
-
Studie: Önsketänkande kan ha väglett beteende under pandemin
En ny doktorsavhandling tyder på att vi systematiskt underskattar hälsorisker – om och när det passar oss. Det gällde inte minst under pandemin då våra riskbedö...
-
A crash course in IP strategy
"Publish, publish, publish!" Sound familiar? So to meet the researcher's wishes, do you scribble a patent application with lipstick on a napkin and send it in? ...
-
Nya Swedenbio satsar mer nordiskt
Nordisk life science får en ny mentor. Swedenbio har bestämt sig för att världen ska upptäcka bolag i Norden som jobbar för nya medicinska behandlingar och lösn...
-
“Register och journalsystem borde vara samma sak”
Sverige ett framgångsrikt land inom medicinsk forskning, men hur ser det ut i dag och hur blir vi världsbäst?
-
Nya kit för genetiska fingeravtryck
Qiagens Investigator-serie tar fram genetiska fingeravtryck vid exempelvis brottsutredningar.
-
Positivt från Idogen
Bolaget rapporterar positiva prekliniska resultat från sin proof-of-concept-studie.
-
Världens snabbaste superdator kan hjälpa till att stoppa coronaviruset
IBM:s superdator har analyserat vilken läkemedelskomponent som skulle kunna vara effektiv i kampen mot att stoppa coronaviruset och i arbetet för att hitta ett ...
-
Major changes to the Q-Med board
The nomination committee wants to replace half of the existing board, including the current Chairman. An Extraordinary General Meeting will take place on February 4.
-
Ökad dödlighet av klorokin och hydroxyklorokin vid covid-19
En stor observationsstudie pekar på att de omtalade malarialäkemedlen mot covid-19 ökade dödligheten på sjukhus. (UPPDATERAD)
-
From planning stage to handshake
"Partnering is an effective tool to get in touch with the decision makers high up in an organization's administration," says Camilla Huse Bondeson at Conlega. A...
-
Astmatiker har DNA-förändringar i immunförsvaret
Barn med astma har DNA-förändringar i vissa celler i immunförsvaret visar en omfattande studie.
-
Seminar program Biotech Forum
Here is the entire seminar program at Biotech Forum September 28-29th
-
EUR 2 million for peanut allergies
ALK Abelló has signed an agreement to invest EUR 2 million in the French biotechnology company DBV Technologies.
-
Klinik igen för Wntresearch
Bolaget planerar att starta klinisk fas 2 med sin kandidat Foxy-5 i patienter med tjocktarmcancer. Ansökan har nu lämnats in till spanska läkemedelsmyndigheten.
-
Early stage research and low turnaround dominates
Nordic science parks are full of advanced research performed by small companies but little research is done in later stages. Only a couple of the best performer...
-
Ideon - Sweden's oldest science park
Old is not synonymous with boring. Swedens oldest science park Ideon still manages to attract young companies with big ideas. The recipe for success? To continu...
-
Discovery of new role for leukemia gene
Martin Bergö and his colleagues have studied two gene variants that often occur in acute leukemias. One gene codes for the protein RAS, which accelerates cell d...
-
Crafoord Prize to an American and two Japanese
Today the Royal Swedish Academy of Sciences announces the laureates of the Crafoord Prize in Polyarthritis 2009.
-
A platform for dialogue
As a step towards connecting the life science industry in Denmark, Biologue was founded three years ago with 10 member companies. Today, the network has 40 memb...
-
International models among science parks
Science parks have become a part of modern communities. With science parks in Oxford, Cambridge and Nice setting good examples, a special potential emerged. Cou...
-
New management at Øresund
The Øresund University has recently appointed a new director and a new Chairman.
-
Blir utvecklingschef
Medicinteknikbolaget Pharmacolog anställer ny utvecklingschef.
-
Medicult acquires embryo scanner
The Danish company Medicult signs an agreement with Novocellus to gain access to embryo selection technology.
BREAKING